BMC Neurology

official impact factor 2.80

Open Access Highly Access Research article

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain

Sibilia Quilici, Jeremy Chancellor*, Mickael Löthgren, Dominique Simon, Gérard Said, Trong K Le, Ana Garcia-Cebrian and Brigitta Monz

BMC Neurology 2009, 9:6 doi:10.1186/1471-2377-9-6

Clarification of study codes

Edward Whitney   (2010-12-23 18:19)  Colorado Division of Workers Compensation email

Some clarification is needed. The pregabalin studies are referred to not by author but by a code. I am in possession of Rosenstock et al (reference #15), and I notice that it enrolled 76 patients on pregabalin 100 mg tid, with 70 patients on placebo. I infer that this is “DPN-131,” though I find this code nowhere in the Rosenstock article, nor do I find a key to the code on the website.
Can this be clarified?

Competing interests

None declared

top

Post a comment